Education
About Us
Working with TipRanks
Follow Us
XBiotech Inc. (XBIT)
:XBIT
Total Valuation
XBiotech has a market cap or net worth of $83.54M. The enterprise value is -$50.46M.
Market Cap$83.54M
Enterprise Value-$50.46M
Share Statistics
XBiotech has 30,487,732 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,487,732
Owned by Insiders21.84%
Owned by Institutions0.70%
Financial Efficiency
XBiotech’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -21.85%.
Return on Equity (ROE)-0.21
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)-21.85%
Return on Capital Employed (ROCE)-0.23
Revenue Per Employee0.00
Profits Per Employee-418.82K
Employee Count92
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of XBiotech is -3.12. XBiotech’s PEG ratio is -0.04.
PE Ratio-3.12
PS Ratio0.00
PB Ratio0.44
Price to Fair Value0.66
Price to FCF-6.93
Price to Operating Cash Flow-7.21
PEG Ratio-0.04
Income Statement
In the last 12 months, XBiotech had revenue of 0.00 and earned -38.53M in profits. Earnings per share was -1.26.
Revenue0.00
Gross Profit0.00
Operating Income-42.47M
Pretax Income-38.56M
Net Income-38.53M
EBITDA-36.01M
Earnings Per Share (EPS)-1.26
Cash Flow
In the last 12 months, operating cash flow was -30.48M and capital expenditures -1.14M, giving a free cash flow of -31.62M billion.
Operating Cash Flow-30.48M
Free Cash Flow-31.62M
Free Cash Flow per Share-1.04
Dividends & Yields
XBiotech pays an annual dividend of $2.47, resulting in a dividend yield of ―
Dividend Per Share$2.47
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.13
52-Week Price Change-50.38%
50-Day Moving Average2.94
200-Day Moving Average4.78
Relative Strength Index (RSI)42.45
Average Volume (3m)49.22K
Important Dates
XBiotech upcoming earnings date is May 9, 2019, TBA Not Confirmed.
Last Earnings DateMar 14, 2019
Next Earnings DateMay 9, 2019
Ex-Dividend DateJul 15, 2021
Financial Position
XBiotech as a current ratio of 11.56, with Debt / Equity ratio of 0.00%
Current Ratio11.56
Quick Ratio11.56
Debt to Market Cap0.09
Net Debt to EBITDA4.51
Interest Coverage Ratio-52.63
Taxes
In the past 12 months, XBiotech has paid -32.00K in taxes.
Income Tax-32.00K
Effective Tax Rate<0.01
Enterprise Valuation
XBiotech EV to EBITDA ratio is 1.17, with an EV/FCF ratio of 1.30.
EV to Sales0.00
EV to EBITDA1.17
EV to Free Cash Flow1.30
EV to Operating Cash Flow1.36
Balance Sheet
XBiotech has $155.90M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$155.90M billion.
Cash & Marketable Securities$155.90M
Total Debt$0.00
Net Cash-$155.90M
Net Cash Per Share-$5.11
Tangible Book Value Per Share$5.98
Margins
Gross margin is 83.77%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin83.77%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for XBiotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―